MICHELE A. GORDON
Chapel Hill,NC
Summary
Multi-talented Senior Marketing Executive able to collaborate successfully with sales, medical affairs, finance, regulatory, legal and compliance teams. Successful at quickly stepping into diverse positions and situations and making immediate positive contributions. Successfully launched 8 new brands in last 8 years in a small-company, limited resource environment. Commercial lead for 20+ due diligence projects. Exceptional at translating scientific and clinical data into simple, actionable sales and marketing messages. Track record of developing strong relationships internally and with external scientific community. Repeated successes in delivering on key priorities, with speed and cost efficiency, while motivating team members and exceeding company goals.
Overview
25
25
years of professional experience
Work History
Vice President, Marketing, Specialty Products Division
MAYNE PHARMA
08.2017 - 04.2024
- Part of leadership team that established new Women's Health Division, including marketing and training support for 90 new sales representatives and managers.
- Successfully launched 4 branded prescription medicines in dermatology and women's health, including Nextstellis, a novel birth control pill with the first new estrogen, estetrol, in 60 years. Nextstellis is now the fastest growing oral contraceptive in the U.S.
- Directed marketing strategies to increase brand awareness and grow market share in competitive, highly genericized categories.
- Led planning, messaging, execution, and measurement of all marketing activities, including DTC advertising, digital marketing, HCP marketing, speaker programs, advisory boards, and sampling activity. Managed sales training to support excellent sales force execution of marketing messages.
- Implemented alternate pharmacy channel to improve prescription fulfillment and company profitability.
- Participated in 10+ due diligence teams to evaluate new acquisitions and in-licensing opportunities
- From July 2017-September 2018, served as interim Business Unit Leader, with sales, marketing, managed care, and pharmacy/trade relations reporting to me.
- Accountable for delivering top-line results and managing within given operating expense budgets
- Integral part of company's management team, including weekly interactions with leadership in all functional areas and regular presentations to the Board of Directors.
Senior Director, Marketing, Specialty Brands
MAYNE PHARMA
08.2016 - 08.2017
- Joined company as part of leadership team to establish first branded pharmaceutical business in the U.S. for Mayne Pharma. Company was in start-up mode with very little infrastructure and no existing commercial team employees.
- Led cross-functional team to successfully launch two branded dermatology medicines within 4 months of joining company. Both products exceeded goals in first year of launch and beyond.
- Achieved company goals by developing and implementing marketing strategies and tactics with a very tight budget.
- Established company as a respected partner, new in the dermatology community, by developing strong key opinion leader relationships.
Senior Director, Global Marketing- Pulmonology
GRIFOLS
05.2015 - 08.2016
- Led global strategy development, geographic expansion plans, and implementation of new tactics to drive double digit growth of Prolastin, a plasma-based infusion treatment for alpha-1 antitrypsin deficiency, a rare genetic disease.
- Led global launch team for Phase III asset in development with external partner.
- Collaborated closely with medical affairs, regulatory, and country-level sales and marketing teams.
- Provided commercial input into clinical programs for new indications and delivery forms of Prolastin.
- Led team in U.S. and Barcelona, Spain.
Global Commercial Leader -Acne and Anti-Infectives
STIEFEL, A GSK COMPANY
12.2010 - 05.2015
- Responsible for in-market global acne and antibacterial brands, including marketing strategies in global markets, including Europe, Asia, and South America.
- Commercial lead for all R&D pipeline and business development opportunities for acne and antifungals. Served as commercial lead on 10+ due diligence teams.
- Launched Duac Low-Dose in Europe and supported Japan in preparing for launch of Duac in 2015.
- Developed global brand campaigns and marketing materials for Duac and Bactroban.
Senior Director - Innovative Commercial Models, Respiratory
GLAXOSMITHKLINE PHARMACEUTICALS
10.2009 - 12.2010
- Developed vision and new strategy for engaging with asthma and COPD healthcare providers, based on partnership to improve health outcomes. Presented plan to GSK leadership and was given approval to implement.
- Launched field-based team of 75 clinically-licensed Respiratory Care Educators
- Uncovered healthcare provider rapidly growing need for support in improving patient outcomes
- Identified role for GSK to support this need by educating providers and their staff on disease/disease management and on ways to use patient education and assessment tools in practice
- Worked cross-functionally with sales leadership, sales training, Care Management, human resources, incentive compensation, legal, clinical, commercial analysis, and IT to develop and execute the plan.
Senior Director - Advair and Flovent Marketing
GLAXOSMITHKLINE PHARMACEUTICALS
04.2006 - 10.2009
- Responsible for development and implementation of brand strategy and marketing to healthcare providers in the asthma and COPD markets.
- Led team of five brand managers.
- Joined team right after new 'Black Box' warning, which had caused a decline in sales for Advair, a $5B brand. Stabilized business, with Advair returning to growth.
- Successfully defended leadership position of combination market (87% share) against first direct competitor, Symbicort (AstraZeneca), launched in June 2007.
- Implemented new asthma portfolio strategy to increase differentiation for Advair and to relaunch Flovent.
- Resulted in above plan growth for Flovent and continued improvement in growth trend for Advair.
Director - HCP Marketing, Migraine
GLAXOSMITHKLINE PHARMACEUTICALS
05.2003 - 04.2006
- Led all marketing activities for Imitrex to healthcare providers, including message development, sales aid development, sample plans, peer-to-peer promotional talks, speaker training, and sales training support.
- Launched Imitrex with RT Technology, a faster-acting tablet, to replace existing Imitrex traditional tablets. Enhanced product differentiation relative to competition.
- Successfully defended 50% market share (leadership) position, despite six competitors in the triptan market.
- Grew migraine market and Imitrex sales by executing 'Is It Sinus or Is It Migraine' campaign.
Director - Migraine/ Imitrex Strategy
GLAXOSMITHKLINE PHARMACEUTICALS
06.2000 - 05.2003
- Developed excellent key opinion leader and professional association relationships.
- Uncovered insight on misdiagnosis of migraine as 'sinus' or 'tension' headache as key factor limiting market growth.
- Developed strategy to grow market based on this insight. Partnered with KOLs and the American Headache Society to create awareness of the prevalence of migraine and the misdiagnosis issue.
- Developed launch strategy for 100 mg (higher) dose of Imitrex Tablets, with early treatment intervention, which demonstrated superior efficacy compared to lower doses.
Director - Business Planning and CNS Team Leader
GLAXO WELLCOME, INC. PHARMACEUTICALS
09.1999 - 06.2000
- Redesigned and implemented new strategic planning process for U.S. Pharmaceuticals Division.
- Led marketing strategy development for key CNS brands for migraine and depression.
Education
Master of Business Administration with Distinction, Director's Honor List -
THE WHARTON GRADUATE SCHOOL OF BUSINESS
Philadelphia, PABachelor of Science, Chemical Engineering, Magna Cum Laude -
UNIVERSITY OF MARYLAND
College Park, MDSkills
- Team Leadership
- Critical Thinking and Analytics
- Cross-Functional Collaboration
- Strategic Business Planning
- Marketing Strategy and Execution
- Operational Excellence
- Performance Measurement
Previous Experiences
- GE CAPITAL, Vice President - Marketing and Strategic Planning
- S. D. WARREN PAPER COMPANY, Director-Corporate Development
- BAIN & COMPANY CONSULTING, Manager
- RJR NABISCO, Director-Business Planning
- HERCULES INCORPORATED, Chemical Engineer
Awards
Winner of 8 GSK Diamond Marketing Excellence Awards
Additional Information
Fluent in French, Proficient in basic Italian and Spanish. Enjoy swimming, running, skiing, and cooking
Timeline
Vice President, Marketing, Specialty Products Division
MAYNE PHARMA
08.2017 - 04.2024
Senior Director, Marketing, Specialty Brands
MAYNE PHARMA
08.2016 - 08.2017
Senior Director, Global Marketing- Pulmonology
GRIFOLS
05.2015 - 08.2016
Global Commercial Leader -Acne and Anti-Infectives
STIEFEL, A GSK COMPANY
12.2010 - 05.2015
Senior Director - Innovative Commercial Models, Respiratory
GLAXOSMITHKLINE PHARMACEUTICALS
10.2009 - 12.2010
Senior Director - Advair and Flovent Marketing
GLAXOSMITHKLINE PHARMACEUTICALS
04.2006 - 10.2009
Director - HCP Marketing, Migraine
GLAXOSMITHKLINE PHARMACEUTICALS
05.2003 - 04.2006
Director - Migraine/ Imitrex Strategy
GLAXOSMITHKLINE PHARMACEUTICALS
06.2000 - 05.2003
Director - Business Planning and CNS Team Leader
GLAXO WELLCOME, INC. PHARMACEUTICALS
09.1999 - 06.2000
Master of Business Administration with Distinction, Director's Honor List -
THE WHARTON GRADUATE SCHOOL OF BUSINESS
Bachelor of Science, Chemical Engineering, Magna Cum Laude -
UNIVERSITY OF MARYLAND
Similar Profiles
Brad Rutkowski PharmD BCPSBrad Rutkowski PharmD BCPS
Medical Science Liaison at MAYNE PHARMAMedical Science Liaison at MAYNE PHARMA
Stephanie GormanStephanie Gorman
Online Medical Representative - Specialty Products at Mayne PharmaOnline Medical Representative - Specialty Products at Mayne Pharma
Alison CoxAlison Cox
Medical Representative at Mayne Pharma, Specialty ProductsMedical Representative at Mayne Pharma, Specialty Products